Voting Rights Announcements | 23 May 2012 14:30


STRATEC Biomedical AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STRATEC Biomedical AG 

23.05.2012 14:30

Dissemination of a Voting Rights Announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.
---------------------------------------------------------------------------


Ameriprise Financial, Inc., Minneapolis, Minnesota, USA, has notified us
pursuant to sec. 21 para. 1 WpHG on 22 May 2012, that on 18 May 2012 the
share of voting rights in STRATEC Biomedical AG, Birkenfeld, Germany, ISIN:
DE0007289001 went above the threshold of 5% and that the percentage of
voting rights on that day amounted to 5.02% (586,136 shares). These voting
rights are attributable to Ameriprise Financial, Inc. pursuant to sec. 22
para. 1 sent. 1 no. 6 in connection with sent. 2 WpHG.



23.05.2012 DGAP's Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de

---------------------------------------------------------------------------
 
Language:     English
Company:      STRATEC Biomedical AG
              Gewerbestr. 37
              75217 Birkenfeld
              Germany
Internet:     www.stratec.com
 
End of Announcement                             DGAP News-Service
 
---------------------------------------------------------------------------